The association of dyslipidemia and obesity with glycated hemoglobin

Table 1 Anthropometric and biochemical parameters in T2DM and control subjects

Parameters (T = 931 subjects)	T2DM (n = 430)	Control (n = 501)	p value
Parameters (T = 931 subjects)	Mean ± SD (range)	Mean ± SD (range)	p value
Anthropometric indices
Age (Yrs.)	56.57 ± 10.52	48.60 ± 12.95	-
Age (Yrs.)	(28.0-86.0)	(25.0-86.0)	-
BMI (Kg/m ² )	27.34 ± 5.12	25.83 ± 4.62	0.092
BMI (Kg/m ² )	(16.26-51.31)	(12.70-47.42)	0.092
WC (cm)	96.88 ± 10.28	92.11 ± 10.72	0.542
WC (cm)	(65.0-142.0)	(64.0-128.0)	0.542
Biochemical Parameters
FPG (mg/dl)	140.79 ± 48.31	88.27 ± 12.39	<0.001^*
PPPG (mg/dl)	189.53 ± 66.85	ND	-
HbA1c (%)	8.18 ± 1.81	5.68 ± 0.51	<0.001^*
FI (uIU/ml)	11.02 ± 6.47	11.97 ± 5.44	0.487
HOMA-IR	3.85 ± 2.30	2.67 ± 1.56	<0.001^*
TC (mg/dl)	181.56 ± 52.01	181.97 ± 46.18	0.008*
TG (mg/dl)	142.04 ± 73.30	112.03 ± 53.80	<0.001^*
HDL-C (mg/dl)	54.24 ± 16.77	56.79 ± 17.33	0.151
LDL-C (mg/dl)	97.94 ± 50.33	102.13 ± 45.14	0.079
Non-HDL-C (mg/dl)	127.32 ± 53.21	125.18 ± 47.10	0.034*

By Independent Student’s t-test, *: Significant, SD: Standard deviation
BMI: Body mass index, WC: Waist circumference, FPG: Fasting plasma glucose, PPPG: Post prandial plasma glucose, HbA1c: Glycated hemoglobin, FI: Fasting Insulin, HOMA-IR: Homeostasis Model of Assessment-Insulin Resistance Index, TC: Total cholesterol, TG: Triglycerides, HDL-C: High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein cholesterol, Non-HDL-C: TC-HDL-C

ISSN: 2055-8260